Home > Healthcare > Analytical Instruments > Molecular Analysis > horseradish peroxidase market
Get a free sample of Horseradish Peroxidase Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Horseradish Peroxidase Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The market for horseradish peroxidase is characterized by fragmentation due to the presence of numerous established and small-scale vendors worldwide offering variety of grades of horseradish peroxidase. Established market players possess extensive experience and significant financial resources to invest in research and development for developing high purity and high sensitivity grade horseradish peroxidase. On the other hand, smaller companies rely on low pricing strategies to compete with established vendors globally.
Prominent players operating in the horseradish peroxidase industry include:
The immunoassays segment held 65.7% of the market share in 2023 and will grow rapidly through 2032, attributed to increasing use of horseradish peroxidase-based antibody assays across diagnostic testing requiring high sensitivity.
The global horseradish peroxidase market size was valued at USD 64.1 million in 2023 and is anticipated to showcase growth at 7.5% CAGR from 2024
North America horseradish peroxidase market accounted for 40.6% share in 2023 and is predicted to reach USD 47.8 million by 2032, attributed to increasing demand of horseradish peroxidase-based assays for diagnostic testing.
Abcam Limited, Abnova Corporation, BBI Solutions, Bio-rad Laboratories, Inc, Creative Enzymes, Enzo Life Sciences, Inc, F. Hoffman-La Roche Ltd., Faizyme Laboratories (Pty) Ltd, GenScript, and Merck KGaA among others.